A simple filter-paper technique allows detection of mucosal cytokine levels in vivo in ulcerative colitis: Interleukin-1 and interleukin-1-receptor antagonist

Digestive Diseases and Sciences

Volumn 41, Issue 9, 1996, Pages 1775-1779

  Hendel, Jakob ^a   Nielsen, Ole H ^a   Madsen, Søren ^a   Brynskov, Jørn ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cytokine; Inflammatory bowel diseases; Interleukin 1 receptor antagonist; Interleukin I; Ulcerative colitis

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ARTICLE; CLINICAL ARTICLE; FEMALE; FILTER; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0029740126     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02088744     Document Type: Article

References (18)

1. Bendtzen K: Cytokines and natural regulators of cytokines. Immunol Lett 43:111-123, 1994
2. Dinarello CA, Wolff SM: Mechanisms of disease: The role of interleukin-1 in disease. N Engl J Med 328(2):106-113, 1993
3. Macdermott RP: Alterations in the mucosal immune system in ulcerative colitis and Crohn's disease. Med Clin North Am 78(6):1207-1231, 1994
4. Brynskov J, Tvede N, Andersen CB, Vilien M: Increased concentrations of interleukin-1β, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut 33:55-58, 1992
5. Ligumsky M: Role of interleukin-1 in inflammatory bowel disease - enhanced production during active disease. Gut 31:686-689, 1990
6. Isaacs KL, Sartor RB, Haskill S: Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 103:1587-1595, 1992
7. Stevens C, Walz G, Singaram C, Lipman ML, Zankar B, Muggia A: Tumor necrosis factor a, interleukin-1β, and interleukin-6 in inflammatory bowel disease. Dig Dis Sci 37:26, 1992
8. Mahida YR, Wu K, Jewell DP: Enhanced production of interleukin-1β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut 30:835-838, 1989
9. Alam R, Sim TC, Hilsmeier K, Grant JA: Development of a new technique for recovery of cytokines from inflammatory sites in situ. J Immunol Methods 155:25-29, 1992
10. Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V: Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 26:1247-1256, 1991
11. Soltoft J, Gudmand-Hoyer E, Krag E, Christensen E, Wulff HR: A double-blind trial of the effect of wheat bran on symptoms of irritable bowel syndrome. Lancet 1:270-272, 1976
12. Binder V: A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucusal exudate in ulcerative colitis. Scand J Gastroenterol 5:627-632, 1970
13. Brynskov J, Nielsen OH, Ahnfelt-Rønne I, Bendtzen K: Cytokines in inflammatory bowel disease. Scand J Gastroenterol 27:897-906, 1992
14. Brynskov J, Nielsen OH, Ahnfelt-Ronne I, Bendtzen K: Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): A review. Dig Dis 12:290-304, 1994
15. Hannum CH: Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336-340, 1990
16. Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG, Holdsworth CD, Duff GW: Novel genetic association between ulcerative colitis and the anti-inflammatory cylokine interleukin-1 receptor antagonist. Gastroenterology 106:637-642, 1994
17. Cominelli F, Nast CC, Duchini A, Lee M: Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 103:65-71, 1992
18. Nishiyama T, Mitsuyama K, Toyonaga A, Sasaki E, Tanikawa K: Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel disease. Digestion 55:368-373, 1994